Stock FinancialsUS public company financials

COOPER COMPANIES, INC. COO

Ophthalmic Goods · Nasdaq

Revenue
$3.59B
+8.6% YoY
Net income
$294.20M
-23.7% YoY
Total assets
$11.66B
+1.4% YoY
EPS
1.48
-23.7% YoY
Gross margin 65.6% Operating margin 14.8% Net margin 8.2% Filings
Advertisement
Income Statement
Period 2026 Q32026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY
Revenues $3.03B $1.97B $964.70M $3.59B $2.88B $1.87B $931.60M $3.31B
Gross Profit $2.03B $1.34B $660.20M $2.36B $1.92B $1.25B $623.80M $2.14B
R&D Expense $130.80M $86.20M $40.70M $137.40M $117.40M $78.40M $39.50M $110.30M
SG&A Expense $1.21B $786.90M $387.90M $1.50B $1.14B $761.20M $380.90M $1.34B
Operating Income (Loss) $542.50M $366.80M $182.00M $533.10M $507.30M $314.80M $153.10M $507.60M
Interest Expense — — — — — — — —
Net Income (Loss) $104.30M $104.30M $104.30M $294.20M $81.20M $81.20M $81.20M $385.80M
EPS (Diluted) 1.45 0.96 0.52 1.48 1.37 0.85 0.41 1.94
Balance Sheet
Period 2026 Q32026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY
Total Assets $12.39B $12.39B $12.39B $11.66B $12.32B $12.32B $12.32B $11.49B
Current Assets $2.11B $2.11B $2.11B $1.95B $1.95B $1.95B $1.95B $1.70B
Cash & Equivalents $124.90M $116.20M $100.90M $120.80M $109.70M $112.40M $135.20M $138.20M
Accounts Receivable $829.00M $829.00M $829.00M $717.00M $717.00M $717.00M $717.00M $609.70M
Inventory $846.00M $846.00M $846.00M $802.70M $802.70M $802.70M $802.70M $735.60M
PP&E (Net) — — — $1.86B — — — $1.63B
Goodwill $3.85B $3.85B $3.85B $3.84B $3.84B $3.84B $3.84B $3.62B
Total Liabilities $4.16B $4.16B $4.16B $4.23B $4.23B $4.23B $4.23B $4.11B
Current Liabilities $1.11B $1.11B $1.11B $1.02B $1.02B $1.02B $1.02B $969.00M
Accounts Payable $300.40M $300.40M $300.40M $260.50M $260.50M $260.50M $260.50M $261.90M
Stockholders Equity $8.24B $8.24B $8.24B $8.08B $8.08B $8.08B $8.08B $7.55B
Cash Flow Statement
Period 2026 Q32026 Q22026 Q12025 FY2025 Q32025 Q22025 Q12024 FY
Operating Cash Flow $548.20M $286.80M $190.60M $607.50M $441.20M $233.70M $122.70M $692.40M
Investing Cash Flow $-274.10M $-176.00M $-96.80M $-449.00M $-523.00M $-398.90M $-324.10M $-1.83B
Financing Cash Flow $-261.50M $-105.20M $-96.60M $-173.90M $67.60M $155.20M $212.30M $1.19B
Stock Repurchases $93.30M $40.60M $0 $0 $0 $0 — $78.50M

Learn more

Data is sourced from the U.S. SEC EDGAR public database. This site does not provide investment advice.